Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026)
Labcorp Holdings' (LH) quarterly Total Non-Current Liabilities came in at $9.2 billion in Q2 2026, up 2.96% year-over-year from $8.9 billion in Q2 2025, and down 4.75% quarter-over-quarter from $9.6 billion in Q1 2026.
Analysis
Labcorp Holdings (LH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $9.2 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 2.96% year-over-year to $9.2 billion; the TTM figure through Jun 2026 stood at $9.2 billion (up 2.96% YoY), while the FY2025 annual figure was $9.1 billion, down 7.01% from the prior year.
- Total Non-Current Liabilities came in at $9.2 billion for Q2 2026 at Labcorp Holdings, down from $9.6 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $9.9 billion in Q3 2024 to a low of $8.1 billion in Q1 2024.
- Average Total Non-Current Liabilities over 5 years is $9.1 billion, with a median of $9.1 billion recorded in 2025.
- The largest YoY upside for Total Non-Current Liabilities was 16.26% in 2024 against a maximum downside of 14.19% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $9.6 billion in 2022, then dropped by 12.59% to $8.4 billion in 2023, then climbed by 16.26% to $9.8 billion in 2024, then slipped by 7.01% to $9.1 billion in 2025, then grew by 0.91% to $9.2 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $9.2 billion in Q2 2026, $9.6 billion in Q1 2026, and $9.1 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 715.49 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 8.06 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 9.19 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 2.01 Bn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 1.86 Bn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 584.41 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 2.59 Bn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 490.00 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 906.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.19 Bn |
| Mar 31, 2026 | 9.65 Bn |
| Dec 31, 2025 | 9.11 Bn |
| Sep 30, 2025 | 8.91 Bn |
| Jun 30, 2025 | 8.93 Bn |
| Mar 31, 2025 | 8.78 Bn |
| Dec 31, 2024 | 9.80 Bn |
| Sep 30, 2024 | 9.90 Bn |
| Jun 30, 2024 | 8.21 Bn |
| Mar 31, 2024 | 8.09 Bn |
| Dec 31, 2023 | 8.43 Bn |
| Sep 30, 2023 | 8.57 Bn |
| Jun 30, 2023 | 8.50 Bn |
| Mar 31, 2023 | 9.43 Bn |
| Dec 31, 2022 | 9.64 Bn |
| Sep 30, 2022 | 9.28 Bn |
| Jun 30, 2022 | 9.50 Bn |
| Mar 31, 2022 | 9.50 Bn |
| Dec 31, 2021 | 9.69 Bn |
| Sep 30, 2021 | 9.83 Bn |